FREQ - Frequency Therapeutics, Inc.

NasdaqGS - NasdaqGS Delayed Price. Currency in USD
Show:
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2022-12-31
2021-12-31
2020-12-31
2019-12-31
Total Revenue
0
0
14,068
36,984
28,947
Operating Expenses
Research Development
49,418
49,418
60,923
37,415
18,784
Selling General and Administrative
33,584
33,584
37,176
27,119
30,838
Total Operating Expenses
83,002
83,002
98,099
64,534
49,622
Operating Income or Loss
-83,002
-83,002
-84,031
-27,550
-20,675
Interest Expense
961
961
764
-
-
Total Other Income/Expenses Net
1,054
1,054
-273
80
145
Income Before Tax
-81,582
-81,582
-84,671
-26,476
-18,746
Income Tax Expense
-2
-2
15
35
-
Income from Continuing Operations
-81,580
-81,580
-84,686
-26,511
-18,746
Net Income
-81,580
-81,580
-84,686
-26,511
-18,746
Net Income available to common shareholders
-81,580
-81,580
-84,686
-26,511
-19,800
Basic EPS
-
-2.33
-2.47
-0.82
-2.29
Diluted EPS
-
-2.33
-2.47
-0.82
-2.29
Basic Average Shares
-
35,076
34,351
32,253
8,649
Diluted Average Shares
-
35,076
34,351
32,253
8,649
EBITDA
-
-80,621
-81,132
-27,550
-20,675